| Prev Close | 247.11 |
| Day Low/High | 245.02 / 247.93 |
| 52 Wk Low/High | 184.50 / 261.27 |
| Avg Volume | 2.27M |
| Exchange | NYSE |
| Shares Outstanding | 335.87M |
| Market Cap | 83.00B |
| EPS | 38.20 |
| P/E Ratio | N/A |
| Div & Yield | 2.80 (1.10%) |
Latest News
Cramer: If There's No Reason for a Rally, Then Something's Wrong
I think caution is warranted if we rally again like this.
All the Rallying Big Bank Stocks Look Very Risky, Doug Kass Says
Doug Kass shares his thoughts on Apple, Google and Starbucks.
Weekly Roundup
Tech rotation, oil and Fed rate hike keep markets on even (make that flat) keel. Several portfolio positions get beefed up.
Opioid Marketing Under Bipartisan Investigation
Individual state investigations of opioid marketing practices has lead to a multistate investigation of the prescription painkiller industry.
Why Alexion's Gain In the C-Suite Doesn't Bode Well For Biogen Takeout Prospects
Paul Clancy's move to another biotech firm could mean that there's nothing imminent in terms of Biogen being bought out, says Mizuho analyst Salim Syed.
Weekly Roundup
After a busy Thursday, markets look forward to economic data and the Fed meeting next week. In the portfolio, we dropped a tech stock and added a healthcare name.
Remember the Rules of the Road
Diversification is the only risk management strategy that will work consistently.
Valeant's Latest Divestiture Seems to Please Investors But Its Massive Debt Still Hovers
Valeant is selling its Australian unit iNova to raise $930 million to pay down debt.
Allergan To Acquire Keller Medical, Inc., Adding Keller Funnel® To Company's Leading Plastic Surgery Portfolio
- Funnel Provides Novel, No-Touch Breast Implant Insertion Device for Plastic Surgeons -
Cramer: 15 Stocks to Buy for the Triathlon of Fear Coming on Super-Thursday
The handwringers will be out in full force. Their fear creates buying opportunities.
Weekly Roundup
Stocks start to recover from recent setbacks. Portfolio moves include a tech-stock downgrade.
Small-Cap Action Is Improving
But I don't have a lot of confidence in this market beyond the intraday action.
Uber's Quarterly Loss was a Staggering $708 Million, Key Exec Leaves
Uber's first quarter loss was less than the $991 million loss reported 3 months ago.
Ohio Going After Drug Makers for Fueling Opioid Crisis
Ohio Attorney General Mike DeWine claims the companies weren't honest with doctors about the risks associated with the painkillers.
Takeaways and Observations; Deep Thoughts: Doug Kass' Views
Doug Kass shares his thoughts on the market, and offers up some especially deep thoughts.
The Good, the Bad and the Ugly; Explaining the Inexplicable: Doug Kass' Views
Doug Kass shares his thoughts on trying to explain that which cannot be explained, and also discusses what was good (and bad and ugly) this week.
Weekly Roundup
Markets rebound amid headlines about oil, Trump and other news. Portfolio moves include an airline downgrade.
Shark Bites: Focus on the 'Little Picture'
Here's what I'm trading today amid the 'flat with a positive tone' action.
Kristin Chenoweth Kicks Off 'Less Red, More You' Campaign To Launch RHOFADE™ (Oxymetazoline HCL) Cream, 1%
REKNOWNED ACTRESS AND SINGER TO HOST LAUNCH EVENT TO RAISE AWARENESS OF NEW TREATMENT FOR PERSISTENT FACIAL REDNESS ASSOCIATED WITH ROSACEA(1)
